RESEARCH-USE BIOSIMILAR ANTIBODY
Olendalizumab
Monoclonal antibody · IgG2
Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus.
TARGETC5
YMonoclonal antibody
CATALOGSC-BS-328
CATALOG NUMBERSC-BS-328
MOLECULAR WEIGHTApprox. 146 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus.
Olendalizumab is a recombinant research-use antibody directed against C5.